Cardiovagal autonomic function in HIV-infected patients with unsuppressed HIV viremia

HIV Clinical Trials

Volumn 12, Issue 3, 2011, Pages 141-150

  Chow, Dominic C ^a   Wood, Robert ^b   Choi, Julia ^a   Grandinetti, Andrew ^c   Gerschenson, Mariana ^a   Sriratanaviriyakul, Narin ^a   Nakamoto, Beau ^a,d   Shikuma, Cecilia ^a   Low, Phillip ^e  

^a UNIVERSITY OF HAWAII   (United States)

^b NEW MEXICO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d STRAUB CLINIC AND HOSPITAL   (United States)

^e MAYO CLINIC   (United States)

Author keywords

acquired immune deficiency syndrome; autonomic dysfunction; heart rate variability; HIV; viremia

Indexed keywords

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BREATHING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; ERADICATION THERAPY; FEMALE; HAND GRIP; HEART RATE VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PARASYMPATHETIC FUNCTION; PARTICIPANT OBSERVATION; PRIORITY JOURNAL; SYMPATHETIC FUNCTION; VIREMIA; VIRUS LOAD;

ADULT; AUTONOMIC NERVOUS SYSTEM DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HEART RATE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; VIREMIA;

EID: 79959480061     PISSN: 15284336     EISSN: 19455771     Source Type: Journal    
DOI: 10.1310/hct1203-141     Document Type: Article

References (42)

1. Aso Y, Wakabayashi S, Nakano T, Yamamoto R, Takebayashi K, Inukai T. High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome. Metabolism. 2006,55:1014-1021 (Pubitemid 44040982)
2. Dallago P, DAgord Schaan B, da Silva VO, et al. Parasympathetic dysfunction is associated with barorefl ex and chemorefl ex impairment in streptozotocin-induced diabetes in rats. Auton Neurosci. 2006
3. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation. 1991,84:482-492
4. Dekker JM, Schouten EG, Klootwijk P, Pool J, Swenne CA, Kromhout D. Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. The Zutphen Study. Am J Epidemiol. 1997;145:899-908 (Pubitemid 27200776)
5. Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med. 1980;49:95-108 (Pubitemid 10039105)
6. Rathmann W, Enck P, Frieling T, Gries FA. Visceral afferent neuropathy in diabetic gastroparesis. Diabetes Care. 1991;14:1086-1089
7. Valensi P, Sachs RN, Harfouche B, et al. Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care. 2001;24:339-343 (Pubitemid 32119135)
8. Toyry JP, Niskanen LK, Lansimies EA, Partanen KP, Uusitupa MI. Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke. 1996,27:1316-1318 (Pubitemid 26286160)
9. Schroeder EB, Liao D, Chambless LE, Prineas RJ, Evans GW, Heiss G. Hypertension, blood pressure, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Hypertension. 2003;42:1106-1111 (Pubitemid 37549063)
10. Singh JP, Larson MG, Tsuji H, Evans JC, ODonnell CJ, Levy D. Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension. 1998;32: 293-297 (Pubitemid 28376487)
11. Singh JP, Larson MG, ODonnell CJ, et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol. 2000,86: 309-312 (Pubitemid 30462227)
12. Liao D, Cai J, Rosamond WD, et al. Cardiac autonomic function and incident coronary heart disease: a population- based case-cohort study. The ARIC Study. Atherosclerosis Risk in Communities Study. Am J Epidemiol. 1997;145:696-706 (Pubitemid 27175281)
13. Carnethon MR, Anthony MS, Cascio WE, et al. Prospective association between hormone replacement therapy, heart rate, and heart rate variability. The Atherosclerosis risk in communities study. J Clin Epidemiol. 2003;56:565-571 (Pubitemid 36842915)
14. Lohmoller G, Matuschke A, Goebel FD. [False-positive test of autonomic neuropathy in HIV infection and AIDS? Case control study of heart rate variability in 62 HIV positive patients]. Med Klin (Munich). 1989,84:242-245
15. Brownley KA, Milanovich JR, Motivala SJ, et al. Autonomic and cardiovascular function in HIV spectrum disease: early indications of cardiac pathophysiology. Clin Auton Res. 2001;11:319-326 (Pubitemid 33096246)
16. Rogstad KE, Shah R, Tesfaladet G, Abdullah M, Ahmed- Jushuf I. Cardiovascular autonomic neuropathy in HIV infected patients. Sex Transm Infect. 1999,75:264-267 (Pubitemid 29420117)
17. Compostella C, Compostella L, DElia R. The symptoms of autonomic dysfunction in HIV-positive Africans. Clin Auton Res. 2008;18:6-12
18. El-Sadr WM, Lundgren JD, Neaton JD, et al. CD4+ countguided interruption of antiretroviral treatment. N Engl J Med. 2006;355:2283-2296 (Pubitemid 44837777)
19. Emery S, Neuhaus JA, Phillips AN, et al. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis. 2008;197:1133-1144 (Pubitemid 351590049)
20. El-Sadr WM, Grund B, Neuhaus J, et al. Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. Ann Intern Med. 2008;149:289-299
21. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996;93:1043-1065
22. Tsuji H, Larson MG, Venditti FJ Jr, et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation. 1996,94:2850-2855 (Pubitemid 26411751)
23. Freeman R. Noninvasive evaluation of heart rate: time and frequency domains. In: Low PA, ed. Clinical Autonomic Disorders. 3rd ed. Philadelphia: Wolters Kluwer Lippincort Williams & Wilkins; 2008:185-197
24. Pomeranz B, Macaulay RJ, Caudill MA, et al. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol. 1985;248:H151-153
25. Pagani M, Lombardi F, Guzzetti S, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res. 1986;59:178-193 (Pubitemid 16017873)
26. Nzuobontane D, Ngu BK, Christopher K. Cardiovascular autonomic dysfunction in Africans infected with human immunodefi ciency virus. J R Soc Med. 2002;95:445-447
27. Cohen JA, Miller L, Polish L. Orthostatic hypotension in human immunodefi ciency virus infection may be the result of generalized autonomic nervous system dysfunction. J Acquir Immune Defi c Syndr. 1991;4:31-33
28. Lebech AM, Kristoffersen US, Mehlsen J, et al. Autonomic dysfunction in HIV patients on antiretroviral therapy: studies of heart rate variability. Clin Physiol Funct Imaging. 2007;27:363-367 (Pubitemid 47604420)
29. Mittal CM, Wig N, Mishra S, Deepak KK. Heart rate variability in human immunodefi ciency virus-positive individuals. Int J Cardiol. 2004;94:1-6 (Pubitemid 38314680)
30. Wulff EA, Wang AK, Simpson DM. HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs. 2000;59:1251-1260 (Pubitemid 30410143)
31. Becker K, Gorlach I, Frieling T, Haussinger D. Characterization and natural course of cardiac autonomic nervous dysfunction in HIV-infected patients. AIDS. 1997; 11:751-757 (Pubitemid 27186945)
32. Yun AJ, Lee PY, Bazar KA. Modulation of host immunity by HIV may be partly achieved through usurping host autonomic functions. Med Hypotheses. 2004;63:362-366 (Pubitemid 38968744)
33. Raymon LP, Kimes AS, Tabakoff B, London ED. [AIDS and sleep disorders: effect of gp120 on cerebral glucose metabolism]. C R Seances Soc Biol Fil. 1989,183:407-418 (Pubitemid 20242672)
34. Chimelli L, Martins AR. Degenerative and inflammatory lesions in sympathetic ganglia: further morphological evidence for an autonomic neuropathy in AIDS. J NeuroAIDS. 2002;2:67-82 (Pubitemid 36358209)
35. Correia D, Rodrigues De Resende LA, Molina RJ, et al. Power spectral analysis of heart rate variability in HIVinfected and AIDS patients. Pacing Clin Electrophysiol. 2006;29:53-58
36. Schifitto G, McDermott MP, Evans T, et al. Autonomic performance and dehydroepiandrosterone sulfate levels in HIV-1-infected individuals: relationship to TH1 and TH2 cytokine profi le. Arch Neurol. 2000;57:1027-1032 (Pubitemid 30452508)
37. Cole SW, Naliboff BD, Kemeny ME, Griswold MP, Fahey JL, Zack JA. Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc Natl Acad Sci USA. 2001,98:12695-12700 (Pubitemid 33020008)
38. Nolte LA, Yarasheski KE, Kawanaka K, Fisher J, Le N, Holloszy JO. The HIV protease inhibitor indinavir decreases insulin- and contraction-stimulated glucose transport in skeletal muscle. Diabetes. 2001;50:1397-1401 (Pubitemid 32500173)
39. Noor MA, Seneviratne T, Aweeka FT, et al. Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study. AIDS. 2002;16:F1-8
40. Alquier T, Leloup C, Arnaud E, Magnan C, Penicaud L. Altered Glut4 mRNA levels in specific brain areas of hyperglycemic-hyperinsulinemic rats. Neurosci Lett. 2001;308:75-78 (Pubitemid 32703671)
41. Siao CJ, Tsirka SE. Extracellular proteases and neuronal cell death. Cell Mol Biol (Noisy-le-grand). 2002;48:151-161
42. Striggow F, Riek-Burchardt M, Kiesel A, et al. Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia. Eur J Neurosci. 2001; 14:595-608 (Pubitemid 34625987)